Comments on: “Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity”
Neuro-Oncology | April 23, 2020 | Volume: 22 | Issue: 9 | Pages: 1404-1405
10.1093/neuonc/noaa112
| PMID 32556220